Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Generic Drugs

Indian pharma has little reason to fear Trump

US tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially cause shortages. Indian firms operate on low margins, making tariff absorption difficult. Recent US manufacturing experiences offer little incentive for relocation. Targeted incentives offer a more direct approach to supply chain…

The Economic Times

Elissa Slotkin Warns Trump's Generic Drug Tariffs Risk Raising Prescription Costs: 'You, the Customer, Will Pay That Price'

Sen. Elissa Slotkin (D-Mich.) warned that President Donald Trump’s proposed tariffs on generic prescription drugs could increase costs for patients, arguing that allowing Medicare to negotiate broader drug prices would be a more effective way to lower healthcare expenses.

Benzinga

Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff plan on imported generic drugs. While generics will remain tariff-free for two years, duties will rise to 100% from August 2028 and 200% from August 2029, weighing…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the immediate impact on exports is likely to be limited, the proposed escalation to 100% and eventually 200% tariffs could significantly alter the economics of supplying generic medicines to the US if…

The Economic Times

Generic Drugs vs Brand-Name Drugs: Are They Really the Same in Safety, Cost, and Effect?

Generic drugs vs brand drugs explained: FDA bioequivalence, cost savings, safety, and therapeutic equivalence for medications and prescriptions.

Medical Daily

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

The Conversation

California to begin selling affordable state-branded insulin beginning next year

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs.

Benzinga

Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major players to seek FDA approvals for generic versions of popular medications, reshaping the competitive landscape and providing more choices for consumers.

Benzinga

Trump says pharmaceutical tariffs are coming ‘very shortly.’ How will this impact the price of drugs?

‘We're going to be announcing very shortly a major tariff on pharmaceuticals. And when they hear that, they will leave China,’ president says at Republican fundraiser

The Independent UK

Gen Z’s expensive drug habit: Younger patients want brand-name meds that are 79% more expensive

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research suggests.

Fortune

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US

How rock-bottom prices drive shortages of generic drugs used in hospitals

Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.

WEKU

Generic drugs to treat four rare diseases launched

Union Health Ministry provides generic drugs to treat 4 rare diseases, slashing costs by 60-100 times. In process of making drugs for more rare diseases available in coming months. Sickle cell drug formulation for children also made available. 8.4-10 cr cases of rare diseases in India, 80% genetic. Health Ministry…

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Health Ministry withdraws fiat mandating doctors prescribe only generic drugs

NMC suspends proposed regulations on prescribing generic drugs, ending stand-off between it and IMA. Health Ministry buys time for both parties, allowing doctors to prescribe drugs with generic names, but no penal provisions. IMA fears poor quality of generic drugs, while NMC says they are cheaper and can reduce health…

The Hindu

Can’t be forced to do the work of chemists or prescribe poor quality drugs to patients: IMA

Indian Medical Association (IMA) demands government intervene to stop forcing doctors to prescribe generic drugs, citing quality concerns. It suggests ordering pharma companies to manufacture drugs without brand names. It questions why branded drugs should be licensed if doctors can't prescribe them.

Dynamite News

Prescribe generic drugs or get penalised, new NMC regulation warns doctors

The National Medical Commission (NMC) in its 'Regulations relating to Professional Conduct of Registered Medical Practitioners" also asked doctors to avoid prescribing branded generic drugs. Read further on Dynamite News:

The Conversation

Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find

Past public ire over high drug prices has recently taken a back seat to a more insidious problem – no drugs at any price.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Generic drugs for diabetes, gastric issues, cardiovascular ailments see high demand

The Jan Aushadhi Kendras selling generic drugs at affordable prices have seen their sales rise more than 170 times over the last nine years, but the government has no intention of making them available online in the near future.

WEKU

Some cancer drugs are in short supply, putting patients' care at risk. Here's why

The recent, abrupt shortage of critical cancer drugs is forcing doctors to ration essential medications. It highlights a broken business model in generic drugs.

The Hindu

Spare the rod and change the law

Given the issues related to quality, it is not appropriate for the DGHS to force doctors to prescribe generic drugs

The Independent UK

Supreme Court revives claims that SuperValu, Safeway overcharged governments for generic drugs

The Supreme Court has unanimously revived whistleblower lawsuits claiming that supermarket and pharmacy chains SuperValu and Safeway overcharged government health-care programs for prescription drugs by hundreds of millions of dollars

The Hindu

Special staff at Karunya pharmacies to sell generic drugs

Thiruvananthapuram

Tribune News Service

Mark Cuban’s pharmacy could have saved Medicare $3.6 billion, researchers find

Medicare could have saved $3.6 billion in a single year if it had bought generic drugs from Mark Cuban’s online pharmacy, according to a Harvard University report.

Tribune News Service

‘Please pay attention’: Scientist flagged heart-pill toxins early on

A scientist at a China-based company that makes crucial ingredients for generic drugs warned a year before the start of a global recall that some blood-pressure pills could become tainted with potentially cancer-causing chemicals, according to court documents.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Harvard Medical School

148 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.